Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined phMRI/phMRS assessment of dose-dependent S-ketamine response in healthy volunteers
NL-OMON49551Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of esketamine (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Change in medial prefrontal cortex GABA level, Change in medial prefrontal cortex glutamate level and 2 more. Started Apr 2021; status: completed.
02
Drugs
esketamine
Beyond the preview
Go deeper on NL-OMON49551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49551.